In Depth 30 May 2025
London: A closer look at the UK capital’s world-renowned biotech hub
Take a closer look at London’s biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure.
In Depth
- Latest Posts
In Depth 28 May 2025
New weight loss drugs: Biotech’s mission to end obesity
Find out more about biotech’s mission to end obesity, as we look at the new weight loss drugs that are in development.
In Depth 28 May 2025
Myasthenia gravis treatments: what’s on the horizon?
Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.
In Depth 26 May 2025
European biotech: trends to watch in 2025
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global policies.
In Depth 21 May 2025
Gene therapy for skin diseases: A field still finding its footing
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of something more?
In Depth 14 May 2025
The stem cell race for Parkinson’s disease: Recent studies show significant promise
Discover how stem cells could be used to treat Parkinson’s disease, as positive early-stage studies in the field show significant promise.
ADVERTISEMENT
ADVERTISEMENT
In Depth 9 May 2025
The Netherlands’ biotech scene: The country sets its sights on becoming a global leader by 2040
With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global biotech leader.
In Depth 7 May 2025
Unlocking immunity: the power of TLR agonists
Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.
In Depth 6 May 2025
The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
In Depth 5 May 2025
The biggest biotech funding rounds in April 2025
The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April 2025
In Depth 2 May 2025
From pandemic spotlight to post-COVID crossroads: What happened to these biotech players?
Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article.
In Depth 30 Apr 2025
The future of NSCLC treatment: what’s in store for the therapeutic space?
Here we delve into the different kinds of NSCLC therapies in the running to potentially address late-stage cancer that is often difficult to treat.
ADVERTISEMENT
